Vivakor, Inc. — Form 8-K Summary
Reporting context: The 8-K reports financing and consulting agreements dated or entered into around July 5, 2024; it was signed July 11, 2024. Vivakor is a Nevada company whose common stock trades on Nasdaq under VIVK. This is an event filing, not a periodic financial-results report.
Financial and Transaction Highlights
- Borrowings: Vivakor received $350,000 from a non-affiliated individual (reported received July 8) and $500,000 from Ballengee Holdings, LLC, controlled by Chairman, President and CEO James Ballengee (received July 5). The loans total $850,000 in principal, bear 10% annual interest and mature December 31, 2024.
- Conversion terms: Both notes permit conversion of principal and interest at 90% of the average closing share price for the five trading days before conversion, subject to a $1.00-per-share floor. Conversion is limited to 4.99% beneficial ownership, potentially increasing to 9.99% after at least 61 days’ notice.
- Equity issued or agreed: The company agreed to issue 15,982 restricted shares in connection with the first loan and 21,552 shares for the related-party loan; the filing says these shares will be issued in the near future.
- Consulting agreement: Vivakor agreed to pay 395 Group, LLC $340,000 in cash and issue 50,000 restricted shares for four months of advisory and business-development services. Half the cash compensation and all shares were due upon signing; the remaining cash payment was due in 30 days. The shares were to be issued in the near future.
- Cash-flow context: The disclosed loan proceeds total $850,000, while the consulting agreement requires $340,000 in cash compensation. The filing does not state the company’s resulting net cash position or explain how proceeds will be used.
- Other financial metrics: Revenue, profit, operating cash flow, margins, existing debt, and liquidity balances are not provided in this filing. No comparable-period results or guidance are given.
Changes, Outlook and Risks
- The transactions add short-term, 10% debt due at the end of 2024 and include conversion features that could dilute existing shareholders. The related-party loan is from an entity controlled by the CEO and board chair.
- The 395 Group agreement creates a substantial cash and equity compensation commitment for advisory services. The filing does not provide performance targets or quantify expected benefits.
- No management outlook, operating guidance, or discussion of contingencies is included.
- The company relied on Securities Act Section 4(a)(2) exemptions for the note-related shares and the 395 Group shares.
Investor Verification Points
- Confirm the issuance of the 15,982 loan-related shares, 21,552 related-party loan shares, and 50,000 consulting shares, and review subsequent filings for any further dilution.
- Review the full note and consulting agreement exhibits for additional terms, including payment, conversion, and default provisions.
- Check subsequent filings for repayment, conversion, or extension of the notes due December 31, 2024, and for updates on liquidity and use of proceeds.
- Assess the related-party transaction and the consulting agreement’s cost and deliverables against the company’s financial position.